cryptococcosi
lead
caus
mening
adult
live
hiv
subsaharan
number
cryptococc
mening
cm
case
region
estim
rang
million
recent
estim
indic
ci
case
cm
includ
death
occur
subsaharan
signific
decreas
absolut
number
case
seem
relat
scaleup
effect
antiretrovir
therapi
art
howev
proport
aidsrel
death
due
cryptococcu
remain
similar
around
repres
second
common
caus
aidsrel
mortal
adult
cryptococc
infect
believ
acquir
inhal
fungal
cell
environ
immunocompet
host
pathogen
clear
establish
latent
immunocompromis
patient
cryptococcu
may
induc
pneumonia
dissemin
central
nervou
system
cn
caus
mening
sever
form
infect
fatal
without
appropri
treatment
low
incom
countri
oneyear
mortal
cm
even
hivinfect
patient
care
estim
high
human
cryptococc
infect
tradit
attribut
cryptococcu
neoforman
cryptococcu
gattii
classifi
distinct
speci
molecular
method
cryptococcu
gattii
divid
four
molecular
type
varieti
gattii
vgivgiv
littl
known
cgatti
infect
africa
pathogen
isol
clinic
environment
vgiv
strain
describ
southern
part
africa
wherea
vgi
vgii
strain
report
central
c
gattii
infect
thought
occur
mainli
outbreak
c
gattii
north
america
outbreak
caus
vgii
strain
includ
emerg
hypervirul
current
knowledg
epidemiolog
clinic
present
c
neoforman
infect
clearli
greater
relat
c
gattii
c
neoforman
infect
occur
predominantli
peopl
infect
hiv
immunocompromis
condit
wherea
c
gattii
infect
mainli
describ
appar
immunocompet
autopsi
find
reveal
cn
lung
organ
frequent
affect
dissemin
may
also
affect
multipl
organ
especi
hivinfect
howev
report
autopsi
seri
usual
includ
cryptococc
speci
identif
therefor
knowledg
regard
histopatholog
c
gattii
remain
limit
present
studi
determin
cryptococcusassoci
mortal
seri
autopsi
perform
two
hospit
locat
high
preval
hiv
area
mozambiqu
subsaharan
africa
brazilian
amazonia
also
analys
clinic
present
manag
histopatholog
microbiolog
find
case
fatal
cryptococc
infect
observ
studi
perform
depart
patholog
maputo
central
hospit
maputo
mozambiqu
de
medicina
tropic
doutor
heitor
vieira
dourado
manau
western
brazilian
amazon
studi
approv
nacion
de
em
pesquisa
conep
brazil
ref
clinic
research
ethic
committe
hospit
clinic
barcelona
spain
file
nation
bioethic
committe
mozambiqu
mozambiqu
ref
deem
verbal
consent
suffici
studi
research
perform
accord
guidelin
regul
montreal
statement
research
integr
crossboundari
research
collabor
singapor
statement
research
integr
novemb
march
complet
diagnost
autopsi
cda
perform
deceas
patient
two
studi
site
two
hundr
twentythre
case
recruit
mozambiqu
adult
year
age
women
matern
death
e
women
die
pregnanc
partum
postpartum
within
day
termin
children
month
year
age
male
femal
sixtyon
case
recruit
brazil
adult
male
femal
includ
one
matern
death
two
children
descript
studi
design
inclus
criteria
case
publish
case
fulfil
inclus
criteria
includ
studi
cda
request
clinician
part
medic
evalu
patient
verbal
inform
consent
perform
autopsi
given
rel
traumat
death
exclud
member
studi
staff
task
liais
famili
case
death
occur
pediatr
depart
clinician
ask
consent
postmortem
clinic
record
avail
regard
admiss
preced
death
patient
review
clinic
data
collect
standard
manner
autopsi
procedur
descript
patholog
microbiolog
method
use
report
briefli
sampl
blood
cerebrospin
fluid
csf
bone
marrow
key
organ
liver
lung
cn
spleen
kidney
well
uteru
women
reproduct
age
collect
histopatholog
microbiolog
analysi
microbiolog
method
includ
univers
screen
relev
pathogen
eg
hiv
viral
hepat
tuberculosi
malaria
bacterialfung
cultur
autopsi
sampl
target
screen
depend
patient
condit
ie
screen
cryptococcu
toxoplasma
gondii
pneumocysti
jirovecii
hivinfect
case
addit
specif
test
accord
histopatholog
find
follow
analysi
cda
sampl
panel
compos
pathologist
microbiologist
clinician
expertis
infecti
diseas
epidemiolog
evalu
data
includ
clinic
inform
assign
final
caus
death
case
caus
death
assign
cryptococc
infect
character
histolog
evalu
includ
period
stain
pa
sampl
lung
cn
bone
marrow
spleen
liver
kidney
uteru
well
grocottgomorimethenamin
silver
stain
cn
sampl
microbiolog
evalu
includ
specif
real
time
pcr
cryptococcu
perform
sampl
lung
cn
bone
marrow
spleen
liver
uteru
pcr
cycl
threshold
valu
consid
neg
plasma
csf
sampl
test
real
time
pcr
cryptococcu
antigen
crag
later
flow
assay
lfa
immi
inc
norman
oklahoma
discrimin
c
neoforman
var
grubii
c
neoforman
var
neoforman
c
gattii
achiev
amplif
rrna
intergen
spacer
ig
region
follow
forward
revers
sanger
sequenc
amplicon
ident
cryptococc
speci
assign
base
match
ig
sequenc
cryptococcu
refer
strain
c
gattii
cb
atcc
cb
atcc
c
neoforman
var
grubii
atcc
atcc
c
neoforman
var
neoforman
atcc
describ
cryptococc
strain
isol
cultur
autopsi
sampl
underw
consensu
multilocu
sequenc
type
scheme
c
neoforman
c
addit
serom
type
strain
determin
multiplex
pcr
describ
antifungogram
perform
strain
use
suscept
plate
trek
diagnost
system
thermo
fisher
scientif
oakwood
villag
usa
descript
analysi
perform
use
univari
statist
mean
standard
deviat
continu
variabl
frequenc
distribut
categor
variabl
analys
data
manipul
implement
done
use
stata
mp
version
stata
colleg
station
tx
usa
among
deceas
patient
includ
studi
test
posit
hiv
total
fatal
cryptococc
infect
confirm
cda
death
except
one
occur
hivinfect
case
among
hivinfect
case
cryptococcosi
respons
death
confid
interv
ci
among
mozambican
adult
hivinfect
die
fatal
cryptococc
infect
four
case
matern
death
three
pregnant
women
one
puerper
period
account
matern
death
occur
hivinfect
women
none
hivposit
children
one
month
age
cryptococc
infect
thirtyseven
patient
brazil
hivinfect
cryptococcu
respons
five
death
death
caus
cryptococcu
hivneg
patient
occur
sixyearold
child
infect
c
gattii
demograph
featur
hiv
statu
clinic
present
manag
patient
fatal
cryptococc
infect
summar
tabl
median
age
year
rang
year
case
men
hivinfect
patient
posit
hiv
test
result
report
clinic
record
appar
unknown
clinician
case
four
hivinfect
patient
art
durat
art
report
one
case
headach
common
symptom
patient
follow
fever
vomit
eight
case
upon
admiss
hospit
eight
patient
confus
andor
agit
two
patient
letharg
anoth
two
fulli
comatos
mening
sign
detect
seven
patient
mean
time
admiss
death
day
ci
cryptococc
infect
consid
first
clinic
diagnost
option
confirm
case
wherea
includ
differenti
diagnosi
eight
patient
antifung
treatment
fluconazol
amphotericin
b
prescrib
seven
patient
five
clinic
suspect
case
seven
patient
die
within
hour
admiss
hivposit
patient
die
within
one
week
admiss
clinic
record
remain
case
includ
studi
review
clinic
diagnosi
cryptococc
infect
among
three
hivinfect
patient
clinic
diagnos
cryptococc
mening
evid
cryptococc
infect
found
autopsi
caus
death
identifi
toxoplasmosi
two
case
tuberculosi
one
case
tabl
show
final
caus
death
cryptococc
speci
associ
diagnos
identifi
cda
well
result
pa
stain
cryptococcu
real
time
pcr
crag
test
differ
sampl
analys
identif
cryptococc
speci
success
case
two
case
tissu
sampl
provid
insuffici
dna
perform
ig
amplif
sequenc
interestingli
among
case
identifi
five
c
gattii
wherea
remain
case
c
neoforman
var
grubii
twelv
case
diagnos
dissemin
infect
remain
meningoencephalitisth
cn
affect
case
follow
affect
organ
pa
andor
pcr
posit
lung
spleen
liver
bone
marrow
kidney
addit
five
six
deceas
women
pathogen
detect
uteru
sampl
one
case
detect
placenta
cryptococcu
found
differ
sampl
patient
case
organ
affect
c
neoforman
var
grubii
c
gattii
infect
mean
vs
organ
posit
pa
stain
specif
histopatholog
differ
observ
two
cryptococcu
speci
molecular
test
expand
detect
cryptococcu
addit
tissu
neg
pa
stain
contrast
two
tissu
sampl
posit
pa
stain
neg
real
time
pcr
period
stain
grocottgomorimethenamin
silver
stain
show
ident
result
repres
histopatholog
imag
differ
affect
tissu
shown
fig
cryptococcu
detect
pcr
csf
plasma
case
test
respect
plasma
csf
sampl
test
crag
lfa
posit
coinfect
aidsrel
pathogen
aidsdefin
ill
mycobacterium
tuberculosi
cytomegaloviru
esophag
candidiasi
toxoplasma
gondii
histoplasma
capsulatum
detect
five
case
eight
strain
isol
cultur
seven
csf
one
blood
molecular
character
antifung
suscept
cryptococc
strain
isol
shown
tabl
c
neoforman
var
grubii
correspond
vni
molecular
type
wherea
two
differ
genotyp
vgi
vgiv
identifi
two
c
gattii
isol
serom
type
found
c
neoforman
isol
strain
found
among
c
gattii
strain
minimum
inhibitori
concentr
mic
varieti
antifung
agent
determin
tabl
triazol
antifung
agent
fluconazol
voriconazol
itraconazol
posaconazol
mic
less
equal
defin
epidemiolog
cutoff
valu
ecv
one
isol
show
mic
flucytosin
one
dilut
higher
ecv
although
isol
present
mic
amphotericin
mic
three
c
neoforman
molecular
type
vni
two
c
gattii
one
dilut
higher
defin
ecv
studi
protocol
receiv
approv
nation
mozambican
ethic
committe
ethic
committe
hospit
clinic
barcelona
spain
approv
file
mia
cda
procedur
conduct
verbal
inform
consent
provid
rel
